ASX - By Stock
|
MSB |
Re:
US analysis confirms MSB pathway to success
|
|
canuck47
|
1 |
1.1K |
13 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
1
|
1.1K
|
13
|
|
ASX - By Stock
|
MSB |
US analysis confirms MSB pathway to success
|
|
canuck47
|
1 |
1.1K |
15 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
1
|
1.1K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
canuck47
|
3.4K |
1.3M |
14 |
16/08/18 |
16/08/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
14
|
|
ASX - By Stock
|
MSB |
Bell Potter recommendation
|
|
canuck47
|
1 |
5.3K |
21 |
28/06/18 |
28/06/18 |
ASX - By Stock
|
1
|
5.3K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MSB Cells Enter Europe!
|
|
canuck47
|
27 |
11K |
16 |
28/03/18 |
28/03/18 |
ASX - By Stock
|
27
|
11K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MSB Cells Enter Europe!
|
|
canuck47
|
27 |
11K |
17 |
28/03/18 |
28/03/18 |
ASX - By Stock
|
27
|
11K
|
17
|
|
ASX - By Stock
|
MSB |
FDA fast track heart failure - Reuters
|
|
canuck47
|
0 |
737 |
14 |
21/12/17 |
21/12/17 |
ASX - By Stock
|
0
|
737
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast's P3 GVHD Trial Completes Enrollment
|
|
canuck47
|
21 |
8.7K |
18 |
20/12/17 |
20/12/17 |
ASX - By Stock
|
21
|
8.7K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
A taste of what's to come
|
|
canuck47
|
45 |
19K |
9 |
19/12/17 |
19/12/17 |
ASX - By Stock
|
45
|
19K
|
9
|
|
ASX - By Stock
|
MSB |
interesting... conflict of interest?
|
|
canuck47
|
74 |
19K |
28 |
16/12/17 |
16/12/17 |
ASX - By Stock
|
74
|
19K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Interesting...
|
|
canuck47
|
218 |
95K |
12 |
15/12/17 |
15/12/17 |
ASX - By Stock
|
218
|
95K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Interesting...
|
|
canuck47
|
218 |
95K |
31 |
12/12/17 |
12/12/17 |
ASX - By Stock
|
218
|
95K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Interesting...
|
|
canuck47
|
218 |
95K |
22 |
12/12/17 |
12/12/17 |
ASX - By Stock
|
218
|
95K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
canuck47
|
840 |
219K |
16 |
01/12/17 |
01/12/17 |
ASX - By Stock
|
840
|
219K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
canuck47
|
840 |
219K |
17 |
01/12/17 |
01/12/17 |
ASX - By Stock
|
840
|
219K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
canuck47
|
840 |
219K |
16 |
24/11/17 |
24/11/17 |
ASX - By Stock
|
840
|
219K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
The biggest critic of mesoblast
|
|
canuck47
|
6 |
2.9K |
13 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
6
|
2.9K
|
13
|
|
ASX - By Stock
|
MSB |
The biggest critic of mesoblast
|
|
canuck47
|
6 |
2.9K |
1 |
22/11/17 |
22/11/17 |
ASX - By Stock
|
6
|
2.9K
|
1
|
|
ASX - By Stock
|
MSB |
followup to stanjupiter's excellent post
|
|
canuck47
|
7 |
2.4K |
16 |
16/11/17 |
16/11/17 |
ASX - By Stock
|
7
|
2.4K
|
16
|
|
ASX - By Stock
|
MSB |
overload
|
|
canuck47
|
9 |
3.1K |
30 |
13/11/17 |
13/11/17 |
ASX - By Stock
|
9
|
3.1K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Back pain stem cell injection
|
|
canuck47
|
136 |
40K |
17 |
05/11/17 |
05/11/17 |
ASX - By Stock
|
136
|
40K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Inflammation - evolution - stem cells - F22 Raptor
|
|
canuck47
|
5 |
3.0K |
8 |
04/09/17 |
04/09/17 |
ASX - By Stock
|
5
|
3.0K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
new to hotcopper
|
|
canuck47
|
59 |
18K |
4 |
10/08/17 |
10/08/17 |
ASX - By Stock
|
59
|
18K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
new to hotcopper
|
|
canuck47
|
59 |
18K |
4 |
10/08/17 |
10/08/17 |
ASX - By Stock
|
59
|
18K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
new to hotcopper
|
|
canuck47
|
59 |
18K |
15 |
10/08/17 |
10/08/17 |
ASX - By Stock
|
59
|
18K
|
15
|
|
ASX - By Stock
|
MSB |
new to hotcopper
|
|
canuck47
|
59 |
18K |
36 |
10/08/17 |
10/08/17 |
ASX - By Stock
|
59
|
18K
|
36
|
|